We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes.
- Authors
Kong, A P S; Yamasaki, A; Ozaki, R; Saito, H; Asami, T; Ohwada, S; Ko, G T C; Wong, C K; Leung, G T C; Lee, K F; Yeung, C Y; Chan, J C N
- Abstract
To examine the efficacy, safety and tolerability of rivoglitazone, a novel thiazolidinedione (TZD), and explore its effects on glucose and lipid control compared to placebo and pioglitazone in Chinese type 2 diabetic patients who are treatment naÏve or treated with a single oral blood glucose-lowering drug.
- Publication
Diabetes, obesity & metabolism, 2011, Vol 13, Issue 9, p806
- ISSN
1463-1326
- Publication type
Journal Article
- DOI
10.1111/j.1463-1326.2011.01411.x